Stay updated on Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial

Sign up to get notified when there's something new on the Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The study record for the ledipasvir/sofosbuvir trial is displayed with its design, participant criteria, treatment arms, outcome measures, results-related dates, and supporting documents.
    Difference
    65%
    Check dated 2026-11-07T14:10:28.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T15:02:45.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A site-wide notice announces changes to NIH terminology and links to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T14:40:25.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2; the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T14:28:28.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T14:31:56.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The page shows a 403 Forbidden error, indicating restricted access to the study record.
    Difference
    0.2%
    Check dated 2026-09-26T17:07:20.000Z thumbnail image

Stay in the know with updates to Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial page.